International Association of
Therapeutic Drug Monitoring and Clinical Toxicology
Fostering education, research and practice in TDM and CT

Interview with Dario Cattaneo, Luigi Sacco University Hospital, Milan

cattaneo 150x175

This month’s interview comes from Milan, Italy, from long-term member, colleague and friend Dr. Dario Cattaneo (who wins my vote for best dancer at the wonderful congress dinner at the St Laurence Cathedral in Rotterdam).  Dario shares his experiences in the worlds of TDM for immunosuppressant and anti-infective drugs, and how recently these worlds have started to intertwine.

 

Dario Cattaneo
Clinical Pharmacologist 
Laboratory of Pharmacokinetics, Clinical Pharmacology Unit
Luigi Sacco University Hospital, Milan, Italy

 

Photo: Dario and colleagues, IATDMCT Congress dinner, Rotterdam, 13/10/15 

What did we learn from the Rotterdam 2015 Congress?

contactus273x169
Social Media
@IATDMCT
After this year’s congress in Rotterdam, The Netherlands, we all went home with some gems to put into practice at work – whether in the clinic, new research ideas or problem solving to better serve patients and clients. We also learned some things about each other: some members have famous children, others are really really great dancers.

 
This month we collected members’ responses to the question “What did you take home with you from the recent congress?”. If you would like to send a response, please Contact the Communications Committee.

Recollections with Dr. Tanaka

IATDMCT2017 Kyoto logo black 150x164With all eyes on the IATDMCT Congess, Tokyo in 2017, we remember the First Congress of the Japanese Society for Therapeutic Drug Monitoring (1st CJSTDM, May 13th 1984) and the First International Congress of Therapeutic Drug Monitoring (1st ICTDM, October 20th 1988).  Dr. Tanaka shares his experiences that led to the beginnings of the Japanese Society, and these two important congresses.

Recollections: The First Congress of Japan Society for Therapeutic Drug Monitoring and the First International Congress of Therapeutic Drug Monitoring

Benefits of Membership - A Presidential Chat

Langman 150x200This month we welcome Loralie Langman as the IATDMCT president for 2015-2017. We asked Loralie and our past and future presidents what they consider the greatest benefit of being members of the association. This is an extension of the interviews conducted in the Compass December 2010 issue.

"What do you consider the greatest benefit of being a member of the IATDMCT?" .

Page 6 of 9

The content of the IATDMCT Blog does not necessarily have the endorsement of the Association.